Q2 2010

Filed Apr 14, 2011 · 10-Q · 45 days after period end · 0001303681-11-000063

Q2 2010 · 10-Q

Revenue—

Net Income

$2.98K

no prior Q2 2009 on file

EPS Diluted

$0.00

no prior Q2 2009 on file

Same quarter

no prior Q2 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Feb 28, 2011 · filed Apr 14, 2011 · 45 d after period end

CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR